IVIRMA Global

IVIRMA Global is the world leader in reproductive medicine, specializing in assisted reproductive technology (ART). With a presence in 15 countries and more than 190 clinics, IVIRMA has helped bring over 200,000 babies into the world and performed more than 150,000 treatments in 2023.

Pillar 1: Scientific Innovation and Technology

IVIRMA leads research in ART through the IVI RMA Global Research Alliance, a scientific platform with over 350 researchers that has published more than 3,000 scientific articles, surpassing competitors in volume. Their research areas include female and male fertility, preimplantation genetics, cryobiology, epigenetics, stem cells, immunology, and reproductive psychology.

Pillar 2: Global Education

IVIRMA Global Education is recognized as a leader in reproductive medicine training. It offers postgraduate programs in collaboration with universities such as the University of Valencia and the European University of Madrid, as well as over 50 online courses covering gynecology, embryology, genetics, and psychology. The organization also provides hands-on clinical training, mentorship programs, and specialized consulting services for professionals in the field.

Pillar 3: Clinical and Operational Excellence

IVIRMA stands out for its focus on clinical quality and operational efficiency. Its organizational model integrates Medical Affairs, Research, Operations, and Global Education departments to ensure high-quality patient care and outstanding clinical outcomes.

Pillar 4: Technology Serving Patients

IVIRMA has implemented advanced technological solutions, such as Mixed Reality using HoloLens 2 and Microsoft Azure, to enhance patients’ understanding of their treatments. These tools allow patients to visualize and better comprehend medical procedures, facilitating communication and informed decision-making.

In summary, IVIRMA Global combines scientific innovation, excellent education, high-quality clinical care, and cutting-edge technology to provide comprehensive solutions in reproductive medicine.